Barclays Maintains Underweight on Virtus Inv, Lowers Price Target to $117

Benzinga · 1d ago
Barclays analyst Benjamin Budish maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $135 to $117.